Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
EPC — Edgewell Personal Care Company
NYSE
FULL STOCK PAGE →

Summary of Edgewell Personal Care Company Q1 2026 Earnings Call

FEB 9, 2026 2 MIN READ
REVENUE
$422.8M -21.3%
NET MARGIN
-15.5% -9.8 PTS
EPS
-$1.41 -113.6%
FREE CASH FLOW
-$137.5M -395.7%

1Key Financial Results and Metrics

Consolidated Organic Net Sales: Decreased by 30 basis points; continuing operations saw a decline of 50 basis points.

Adjusted EPS: Reported at a loss of $0.16, compared to a loss of $0.10 in the prior year.

Adjusted EBITDA: $25 million, down from $30.9 million year-over-year.

Adjusted Operating Income: $8.1 million (1.9% of net sales), down from $15.9 million (3.8% of net sales) last year.

Gross Margin: Decreased by 210 basis points, impacted by inflation and tariffs but supported by productivity gains of 240 basis points.

Net Cash Used by Operating Activities: $125.9 million, compared to $115.6 million last year.

Dividend: Declared at $0.15 per share, returning approximately $7 million to shareholders.

2Strategic Updates and Business Highlights

Divestiture of Feminine Care Business: Closed on February 2, 2026, marking a strategic shift to focus on core categories: Shave, Sun, Skincare, and Grooming.

Performance in North America: Strong growth in Sun Care (nearly 20%) and Grooming (approximately 7%), offsetting declines in Wet Shave and Skin Care.

International Markets: Organic net sales decreased by 1.6%, but growth was noted in Oceania and Greater China.

Innovation Pipeline: New product launches planned for Q3 and Q4, including Wilkinson Sword and Hawaiian Tropic, with increased marketing investment behind key brands.

3Forward Guidance and Outlook

Fiscal 2026 Outlook:

Organic net sales expected to range from a decline of 1% to growth of 2%.

Anticipated gross margin rate growth of 60 basis points year-over-year.

Adjusted EPS projected between $1.70 and $2.10, incorporating a $0.44 headwind from the feminine care divestiture.

Adjusted EBITDA expected to be in the range of $245 million to $265 million, including a $44 million headwind from the divestiture.

Focus on improving free cash flow, projected between $80 million and $110 million for the year.

4Bad News, Challenges, or Points of Concern

Declining Metrics: Organic net sales decreased, particularly in Wet Shave and Skin Care, with market share pressures noted in core categories.

Promotional Environment: High promotional intensity in Wet Shave, especially in women's categories, contributing to competitive pressures.

Inflation and Tariffs: Continued impact from inflation and tariffs, with a projected $25 million net impact from tariffs affecting margins.

Stranded Costs: Ongoing adjustments needed to address stranded costs post-divestiture, which may affect profitability in the near term.

5Notable Q&A Insights

Portfolio Construction and M&A: Management emphasized focusing on core categories and using divestiture proceeds for debt reduction rather than pursuing M&A.

Sales Phasing: Q2 expected to see a decline in organic sales due to shipment timing, with a return to growth anticipated in the second half of the year.

Feminine Care Impact: The divestiture is expected to have a significant impact on adjusted EPS and EBITDA, but management is confident in a stronger, more focused portfolio moving forward.

Retail Inventory Levels: No significant issues with retail inventory were reported; unit share is up despite value share being flat, indicating healthy category dynamics. Overall, Edgewell Personal Care Company reported a solid start to fiscal 2026, with strategic initiatives aimed at enhancing focus and profitability, despite facing challenges in specific categories and external pressures.

SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT